WIL buys Ricerca's Lyon site; Sponsors, CROs still tinkering with partnering models;

> WIL Research has bought Ricerca Biosciences' pharmaceutical services hub in Lyon, France, adding to its European nonclinical safety assessment capabilities. Article

> Two Michigan CROs, PharmOptima and Ophthy-DS, have united to offer ocular R&D services to clients around the globe. More

> CRO Advance Research Associates has teamed up with clinical study management outfit MedNet Solutions for biostatistical work. News

> MicroConstants has expanded its biomarker testing services, adding capabilities in multiplex immunoassays, gene expression and profiling assays. Item

> Sponsors are putting more and more responsibility on their CRO partners, but no one has created a perfect model for risk-sharing, executives say. Story

Suggested Articles

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.